All In MedTech

Device Trial Radar · NCT07529015

Acoustic Stimulation During Sleep: Effects on Memory and p-tau217 in MCI

The Impact of Phase-locked Acoustic Stimulation on Sleep Structure, Memory Consolidation, and Plasma p-tau217 in Patients With Mild Cognitive Impairment

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 114 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

114

Planned (sponsor's estimate)

Start

Dec 2026

Primary completion

Dec 2027

Study completion Dec 2028

Sponsor

Sponsor type
Academic, hospital or other
First posted
Apr 14, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to determine whether acoustic stimulation during sleep can enhance slow-wave sleep (SWS), improve cognitive function, and reduce AD-related pathology in individuals with mild cognitive impairment (MCI), compared with cognitively healthy participants. The main questions it aims to answer are: 1. Does acoustic stimulation increase SWS (e.g., slow oscillation and sleep spindle activity) in individuals with MCI? 2. Does enhancing SWS lead to improvements in memory and cognitive performance? 3. Does acoustic stimulation influence plasma p-tau217 levels as a marker of underlying Alzheimer's disease pathology? Researchers will compare participants receiving acoustic stimulation during sleep with those not receiving stimulation to evaluate its effects on sleep architecture, cognition, and plasma biomarkers. Participants will: * Undergo sleep recordings to assess sleep architecture, including SWS, slow oscillations, and sleep spindles * Receive acoustic stimulation during sleep across multiple nights * Complete cognitive assessments, particularly memory-related tasks * Provide blood samples to measure plasma p-tau217 levels * Provide clinical and demographic information for analysis

Conditions

  • Alzheimer's Disease (AD)
  • Mild Cognitive Impairment (MCI) Amnestic
  • Cognitively Unimpaired

Interventions

  • Plase-Locked Acoustic Stimulation during slow-wave sleepDevice

    Participants will wear a mobile, wearable EEG device during sleep. Sleep will be recorded using EEG, and an algorithm will detect slow oscillations (SOs; \>1 Hz). In the real-PLAS arm, acoustic stimulation will be applied in phase with the up-state of these slow oscillations. Specifically, the algorithm will detect each SO and trigger brief pink-noise bursts synchronized with the up-state phase, ensuring phase-locked acoustic stimulation (PLAS) is delivered precisely to enhance slow-wave activity.

  • Phase-locked acoustic stimulation-Sham conditionDevice

    Participants will have the same setup as in the real-PLAS arm, wearing a mobile, wearable EEG device during sleep. Sleep will be recorded using EEG, and an algorithm will detect slow oscillations (SOs; \>1 Hz). No acoustic stimulation will be applied in the sham-PLAS arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Impact on SWS: SO and sleep spindle densityTime frame: 14 nights
  2. Impact on SWS: SO and sleep spindle durationTime frame: 14 nights
  3. Impact on SWS: SO and sleep spindle peak-to-peak amplitudeTime frame: 14 nights

7 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hospital Universitari Santa Maria de Lleida

    Lleida, Catalonia, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.